Results 291 to 300 of about 1,417,591 (372)
Detecting Opioid Use Disorder in Health Claims Data With Positive Unlabeled Learning. [PDF]
Kumar P+13 more
europepmc +1 more source
The Long Arc of Substance Use Policy Innovation in Medicaid: Looking Back, Looking Forward
Policy Points The role of Medicaid in financing, organizing, and delivering substance use disorder (SUD) treatment has grown tremendously over time owing to expansions of eligibility and a push toward more uniformity in benefits. Current innovations in SUD treatment focus on expanding the delivery system to create a comprehensive continuum of care ...
BRENDAN SALONER
wiley +1 more source
Medicaid managed care restrictions on medications for the treatment of opioid use disorder
Abstract Objective To examine whether Medicaid managed care plan (MCP) utilization management policies for buprenorphine–naloxone and injectable naltrexone are related to key state Medicaid program policy decisions. Data Sources and Study Setting We abstracted data on state Medicaid regulatory and policy information from publicly available sources and ...
Maureen T. Stewart+6 more
wiley +1 more source
Tele-Buprenorphine Initiations for Opioid Use Disorder Without In-Person Relationships.
McGinty EE+4 more
europepmc +1 more source
A New Holistic Theoretical Framework to Inform Opioid Use Disorder Management. [PDF]
Coffee Z+4 more
europepmc +1 more source
ABSTRACT Objective To estimate associations between Wisconsin Medicaid's Prenatal Care Coordination (PNCC) program and infant mortality. Data Sources and Study Setting We analyzed birth records, Medicaid claims, and infant death records for all resident and in‐state Medicaid‐paid live deliveries during 2010–2018.
David C. Mallinson+3 more
wiley +1 more source
Outpatient tapering of buprenorphine in opioid use disorder pregnancies may improve neonatal outcomes. [PDF]
Shah D+4 more
europepmc +1 more source
ABSTRACT Objective To evaluate the association between patient–provider race concordance and the likelihood of being screened for suicide risk in Veterans Health Administration (VA) primary care settings. Study Setting and Design In November 2020, the VA expanded its national suicide risk identification strategy to include an annual universal suicide ...
Linda Diem Tran+4 more
wiley +1 more source
Medication for Opioid Use Disorder in Federally Qualified Health Centers.
Lindenfeld Z, Mauri AI.
europepmc +1 more source